Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantation

Simple item page
dc.citation.issueNumber3en_US
dc.citation.journalTitleHaematologicaen_US
dc.citation.volumeNumber106en_US
dc.contributor.authorWiebking, Volkeren_US
dc.contributor.authorLee, Ciaran M.en_US
dc.contributor.authorMostrel, Nathalieen_US
dc.contributor.authorLahiri, Premanjalien_US
dc.contributor.authorBak, Rasmusen_US
dc.contributor.authorBao, Gangen_US
dc.contributor.authorRoncarolo, Maria Graziaen_US
dc.contributor.authorBertaina, Aliceen_US
dc.contributor.authorPorteus, Matthew H.en_US
dc.contributor.orgBioengineeringen_US
dc.date.accessioned2021-04-21T15:46:12Zen_US
dc.date.available2021-04-21T15:46:12Zen_US
dc.date.issued2021en_US
dc.description.abstractAllogeneic hematopoietic stem cell transplantation is an effective therapy for high-risk leukemias. In children, graft manipulation based on the selective removal of αβ T cells and B cells has been shown to reduce the risk of acute and chronic graft-versus-host disease, thus allowing the use of haploidentical donors which expands the population that allogeneic hematopoietic stem cell transplantation can be used in. Leukemic relapse, however, remains a problem. T cells expressing chimeric antigen receptors can potently eliminate leukemia, including in the central nervous system. We hypothesized that by modifying donor αβ T cells to simultaneously express a CD19-specific chimeric antigen receptors and inactivating the T cell receptor by genome editing, we could create a therapy that enhances the anti-leukemic efficacy of the stem cell transplant without increasing the risk of graft-versus-host disease. Using genome editing with Cas9 ribonucleoprotein and adeno-associated virus serotype 6, we integrate a CD19-specific chimeric antigen receptor in-frame into the TRAC locus. Greater than 90% of cells lost TCR expression, while >75% expressed the CAR. The product was further purified to ultimately have less than 0.05% residual TCR+ cells. In vitro, the CAR T cells efficiently eliminated target cells and produced high cytokine levels when challenged with CD19+ leukemia cells. In vivo, the gene modified T cells eliminated leukemia without causing xenogeneic graft-versus-host disease in a xenograft model. Gene editing was highly specific with no evidence of off-target effects. These data support the concept that the addition of αβ T cell-derived, genome edited T cells expressing CD19-specific chimeric antigen receptors could enhance the anti-leukemic efficacy of αβ T cell-depleted haploidentical hematopoietic stem cell transplantation without increasing the risk of graft-versus-host disease.en_US
dc.identifier.citationWiebking, Volker, Lee, Ciaran M., Mostrel, Nathalie, et al.. "Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantation." <i>Haematologica,</i> 106, no. 3 (2021) Ferrata-Storti Foundation: https://doi.org/10.3324/haematol.2019.233882.en_US
dc.identifier.digital9701-71341-2-10-20210222en_US
dc.identifier.doihttps://doi.org/10.3324/haematol.2019.233882en_US
dc.identifier.urihttps://hdl.handle.net/1911/110289en_US
dc.language.isoengen_US
dc.publisherFerrata-Storti Foundationen_US
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/en_US
dc.titleGenome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantationen_US
dc.typeJournal articleen_US
dc.type.dcmiTexten_US
dc.type.publicationpublisher versionen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
9701-71341-2-10-20210222.pdf
Size:
2.58 MB
Format:
Adobe Portable Document Format
Download
Collections
Faculty Publications